Guidelines

Practical recommendations for the management of late relapsed and refractory multiple myeloma in 2024

October 2024
Current advances in cytogenomics – Implementation of Optical Genome Mapping into diagnostic workflows for haematological neoplasms: A Belgian Cytogenomic Group for Haemato-Oncology (BCG-HO) position statement

October 2024
Updated BHS guidelines for the treatment of diffuse large B-cell lymphoma (DLBCL): Novelties anno 2024

June 2024
Multiple myeloma: Practical recommendations for the management of early relapses 2024

June 2024
Multiple myeloma: Practical recommendations for front-line therapy 2024

May 2024
BHS guidelines for the management of small lymphocytic lymphoma and chronic lymphocytic leukaemia, anno 2024

November 2023
BHS guidelines on the management of relapsed and refractory diffuse large B-cell lymphoma: Part 2

June 2023
Diagnosis and treatment of Waldenström Macroglobulinaemia

May 2023
BHS guidelines on the management of relapsed and refractory diffuse large B-cell lymphoma: Part 1

May 2023
Venetoclax-Azacitidine, the new standard of care for AML patients unfit for intensive treatment: A guide for clinical practice

March 2023

Top